RLMD - RELMADA THERAPEUTICS, INC.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 3.83

Open

$ 3.80

Bid

$ 0.00 x 0

Ask

$ 3.85 x 100

Day's Range

$ 3.80 - $ 3.84

52 Week Range

$ 2.36 - $ 7.22

Volume

52,697

Average Volume

Market Cap

115.57M

Beta (5Y Monthly)

$ 0.87

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	03-19-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-23-2023	12-31-2022	10-K
7	11-10-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	03-25-2022	12-31-2021	10-K
11	11-12-2021	09-30-2021	10-Q
12	08-10-2021	06-30-2021	10-Q
13	05-12-2021	03-31-2021	10-Q
14	03-24-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q
16	08-12-2020	06-30-2020	10-Q
17	05-15-2020	03-31-2020	10-Q
18	11-13-2019	09-30-2019	10-Q
19	09-24-2019	06-30-2019	10-K
20	05-15-2019	03-31-2019	10-Q
21	02-13-2019	12-31-2018	10-Q
22	11-13-2018	09-30-2018	10-Q
23	09-28-2018	06-30-2018	10-K
24	05-14-2018	03-31-2018	10-Q
25	02-12-2018	12-31-2017	10-Q
26	11-14-2017	09-30-2017	10-Q
27	09-28-2017	06-30-2017	10-K
28	05-15-2017	03-31-2017	10-Q
29	02-10-2017	12-31-2016	10-Q
30	11-10-2016	09-30-2016	10-Q
31	09-09-2016	06-30-2016	10-K
32	05-09-2016	03-31-2016	10-Q
33	02-05-2016	12-31-2015	10-Q
34	11-06-2015	09-30-2015	10-Q
35	09-11-2015	06-30-2015	10-K
36	05-15-2015	03-31-2015	10-Q
37	02-13-2015	12-31-2014	10-Q
38	11-07-2014	09-30-2014	10-Q
39	04-15-2014	02-28-2014	10-Q
40	01-13-2014	11-30-2013	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Relmada Therapeutics Q1 2024 GAAP EPS $(0....
05/08/2024 21:21:20

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of ...

Relmada Therapeutics Q4 EPS $(0.84) Misses...
03/19/2024 20:33:19

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate o...

Recap: Relmada Therapeutics Q4 Earnings
03/19/2024 20:30:05

Relmada Therapeutics 2023 EPS $(3.28)
03/19/2024 20:22:06

Earnings Scheduled For March 19, 2024
03/19/2024 10:06:23

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per...

Earnings Outlook For Relmada Therapeutics
03/18/2024 14:01:43

relmada-therapeutics-and-2-other-penny-stocks-insiders-are-buying

Relmada Therapeutics And 2 Other Penny Sto...
02/01/2024 13:42:54

The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates thei...

Relmada Therapeutics CEO Sergio Traversa R...
01/31/2024 23:57:49

why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Mobileye Global Shares Are Trading Low...
01/04/2024 18:37:44

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
01/04/2024 17:31:11

Relmada Therapeutics Provides Corporate Up...
01/04/2024 12:39:47

Relmada Therapeutics Q3 EPS $(0.73) Beats ...
11/08/2023 22:40:16

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of ...

Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

Earnings Outlook For Relmada Therapeutics
11/07/2023 20:01:40

Relmada Therapeutics To Present New Precli...
10/11/2023 12:41:03

Low-dose psilocybin generated statistically significant reductions in liver fat content, plasma glucose levels and body weight ...

Relmada Therapeutics To Present Data From ...
10/06/2023 11:32:24

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
09/21/2023 13:06:04

relmada-therapeutics-lead-candidate-shows-promise-in-pivotal-depression-study

Relmada Therapeutics' Lead Candidate Shows...
09/20/2023 17:06:53

Relmada Therapeutics Inc (NASDAQ: RLMD) announced efficacy results for the de novo (or new to treatment) patients (204 patients...

Relmada Therapeutics Announces Efficacy An...
09/20/2023 12:31:02

Patients newly treated with REL-1017 for up to one year experienced rapid, clinically meaningful, and sustained improvements in...

Relmada Therapeutics Announced The Dosing ...
08/23/2023 11:31:43